Rational design and preclinical evaluation of unimolecular multi-agonist peptide therapeutics for obesity and related metabolic disease
Ulster University - Coleraine Campus
Faculty of Life and Health Sciences
Research Group:
Biomedical Sciences
OPEN TO UK AND REPUBLIC OF IRELAND STUDENTS ONLY. The success of GLP-1-based medicines such as semaglutide, as well as related and multi-agonist drugs such as tirzepatide, has demonstrated the therapeutic potential of targeting multiple metabolic pathways to treat obesity and related disease. Read more
Supervisors: Prof N Irwin, Prof P Flatt
8 January 2027
PhD Research Project
Competition Funded PhD Project (UK Students Only)